Business Description
Synaptogenix Inc
NAICS : 541714
SIC : 2833
ISIN : US87167T2015
Share Class Description:
SNPX: Ordinary SharesDescription
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.58 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 56.9 | |||||
| 3-Year EPS without NRI Growth Rate | 51.3 | |||||
| 3-Year FCF Growth Rate | 59.1 | |||||
| 3-Year Book Growth Rate | -37.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 34.97 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.03 | |||||
| 9-Day RSI | 41.14 | |||||
| 14-Day RSI | 43.97 | |||||
| 3-1 Month Momentum % | -13.35 | |||||
| 6-1 Month Momentum % | -37.34 | |||||
| 12-1 Month Momentum % | -55.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 65.34 | |||||
| Quick Ratio | 65.34 | |||||
| Cash Ratio | 64.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -167.6 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -37.77 | |||||
| ROA % | -28.52 | |||||
| ROIC % | -1485.29 | |||||
| 3-Year ROIIC % | 508.41 | |||||
| ROC (Joel Greenblatt) % | -39325.58 | |||||
| ROCE % | -27.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.28 | |||||
| Price-to-Tangible-Book | 0.28 | |||||
| EV-to-EBIT | 2.62 | |||||
| EV-to-Forward-EBIT | -1.55 | |||||
| EV-to-EBITDA | 2.62 | |||||
| EV-to-FCF | 3.79 | |||||
| Price-to-Net-Current-Asset-Value | 0.3 | |||||
| Price-to-Net-Cash | 0.29 | |||||
| Earnings Yield (Greenblatt) % | 38.17 | |||||
| FCF Yield % | -131.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SNPX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synaptogenix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -7.446 | ||
| Beta | 1.56 | ||
| 3-Year Sharpe Ratio | -1.46 | ||
| 3-Year Sortino Ratio | -1.48 | ||
| Volatility % | 45.56 | ||
| 14-Day RSI | 43.97 | ||
| 14-Day ATR ($) | 0.238484 | ||
| 20-Day SMA ($) | 2.763855 | ||
| 12-1 Month Momentum % | -55.94 | ||
| 52-Week Range ($) | 2.32 - 8.775 | ||
| Shares Outstanding (Mil) | 1.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synaptogenix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synaptogenix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synaptogenix Inc Frequently Asked Questions
What is Synaptogenix Inc(SNPX)'s stock price today?
The current price of SNPX is $2.69. The 52 week high of SNPX is $8.78 and 52 week low is $2.32.
When is next earnings date of Synaptogenix Inc(SNPX)?
The next earnings date of Synaptogenix Inc(SNPX) is 2025-02-12 Est..
Does Synaptogenix Inc(SNPX) pay dividends? If so, how much?
Synaptogenix Inc(SNPX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers